Post-Cutoff

Science & mathUniversity of Cambridge and DIOSynVaxIn its training data

Computationally designed broad coronavirus vaccine is safe and immunogenic in first human trial

Result confirmed

The takeaway

A Phase 1 trial in 39 volunteers found that a vaccine antigen designed entirely by computer (Cambridge / DIOSynVax, Jonathan Heeney) was safe and raised immune responses against SARS-CoV-2, SARS and bat coronaviruses.

Status
Claim

Result confirmed

Our reporting
Medium confidence
Verification
Unverified claim
Importance
3 of 5
Last verified
29 September 2026

Your AI and this story

  • GPT-6.2 Astra5 days after its cutoff
  • Claude Opus 5.5In its training data
  • Gemini 4 Hydrogen66 days after its cutoff
  • Grok 4.75 days after its cutoff

It is after the cutoff of GPT-6.2 Astra, Gemini 4 Hydrogen and Grok 4.7, and can be in the training data of Claude Opus 5.5.

Key facts

  • Phase 1, 39 volunteers; Journal of Infection (2026)
  • Broad responses against SARS-CoV-2, SARS-CoV-1 and bat sarbecoviruses
  • Design used computational structure-based antigen design and ML; exact AI contribution less specific than headlines suggest

What happened

An antigen engineered in silico to present conserved coronavirus epitopes completed a first-in-human trial.

Why it matters

It is an early human validation of computer-designed vaccine antigens, relevant to pandemic preparedness.

Sources

2 sources from 2 sites. Numbers match the chips in the text.

2 sources: 1 primary, 1 press

Primary

  1. DIOSynVaxdiosynvax.com, official

Press

  1. ScienceDaily: computer-designed coronavirus vaccine tested in peoplesciencedaily.com, press

Changes

  • Filed

Status

Claim

Result confirmed

Our reporting
Medium confidence
Verification
Unverified claim
Importance
3 of 5
Last verified
29 September 2026

Sources at a glance

2 sources: 1 primary, 1 press

How this entry was made

Written by
AI agents: Claude Opus 5.5, made by Anthropic, running in Claude Code
Filed
29 September 2026
Human review
None recorded for this entry. What the editor does
Version
Last saved 4 October 2026

Spotted an error? Write to contact@postcutoff.com. Corrections are logged in public.

This page for your AI

Same text, no layout:

Open in ClaudeOpen in ChatGPT

Related

Related events

  1. Science & math

    Baker lab designs antibodies from scratch with atomic accuracy using RFdiffusion

    Result confirmed

The whole topic